Delcath Systems Inc (DCTH.O)

DCTH.O on Consolidated Issue listed on NASDAQ Capital Market

1.03USD
17 Apr 2015
Change (% chg)

$-0.03 (-2.83%)
Prev Close
$1.06
Open
$1.05
Day's High
$1.08
Day's Low
$1.00
Volume
70,729
Avg. Vol
133,595
52-wk High
$4.10
52-wk Low
$0.91

DCTH.O

Chart for DCTH.O

About

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. The Company's principal focus is on the treatment of primary and metastatic liver cancers. The Company’s product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to... (more)
No analyst recommendations are available for DCTH.O.

Overall

Beta: 1.98
Market Cap(Mil.): $12.53
Shares Outstanding(Mil.): 12.17
Dividend: --
Yield (%): --

Financials

  DCTH.O Industry Sector
P/E (TTM): -- 41.77 41.57
EPS (TTM): -1.84 -- --
ROI: -70.01 10.89 16.05
ROE: -72.05 12.69 16.88
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks